NEW YORK and MAINZ, GERMANY, February 12, 2021 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. government has exercised its option for an additional 100 million doses of the Pfizer-BioNTech COVID-19 vaccine. This brings the total number of doses to be supplied by the companies to the U.S. government to 300 million.

Read more here:
Pfizer and BioNTech to Supply the United States with 100 Million Additional Doses of COVID-19 Vaccine

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh